The let-7 family of microRNAs.
By Sarah F. Roush, Frank J. Slack. Trends in Cell Biology, 2008
1,381 citations recorded by the source corpus.
Subfields: Cancer Research, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/eea845846605f69c5f0605d2dea60162830ad382
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
- John S. Mattick
- H. Horlings
- V. Narry Kim
- Thomas Tuschl
- Marcel E. Dinger
- M. Siomi
- Young‐Kook Kim
- David P. Bartel
In Molecular Biology
- John S. Mattick
- V. Narry Kim
- H. Horlings
- David P. Bartel
- Thomas Tuschl
- Marcel E. Dinger
- M. Siomi
- Young‐Kook Kim
Citations in the corpus
- Non‐coding RNAs: regulators of disease (2010, background): “The let-7 family of miRNAs is highly conserved throughout the Metazoa and functions as a master temporal regulator of development and differentiation, both in early embryos and complex adult tissues such as brain, in nematode, fruitfly, zebrafish and mouse [61–67].”
- The widespread regulation of microRNA biogenesis, function and decay (2010, background): “Let-7 functions as a tumour suppressor by targeting several oncogenes, including MYC , KRAS and cyclin D1 ( CCND1”
- Cardiac fibrosis in myocardial infarction—from repair and remodeling to regeneration (2016, background): “The Let-7 family of miRNAs also function as suppressors of stem cell pluripotency by regulating the expression of pluripotency genes Oct4 and Sox2 (Roush and Slack 2008).”
- MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer (2015, background): “let-7 miRNAs have been demonstrated to regulate multiple oncogenes, such as RAS, high-mobility group AT-hook 2 (HMGA2), c-Myc, and caspase-3 [177-180], and several genes involved in the maintenance of stem cell phenotype [181].”
- Posttranscriptional regulation of microRNA biogenesis in animals. (2010, background): “While most let-7 pri-miRNA transcripts are highly expressed throughout development, the mature let-7 is detectable only in highly differentiated cells, suggesting a posttranscriptional regulation of biogenesis (Roush and Slack, 2008).”
- miRNAs in human cancer (2010, background): “let-7 family Ubiquitous Multiple members (chromosomes 3, 9, 11, 19, 21, 22) TS CLL [119], lymphoma [120], gastric [121], lung [122], prostate [9], breast [123], ovarian [121], colon [121], leiomyoma [121], melanoma [121] miR-15a/16-1 cluster Ubiquitous 13q14.”
- The Genetic Signatures of Noncoding RNAs (2009, background): “elegans, not in other organisms, despite the former being not only highly conserved in sequence and expression pattern throughout metazoan evolution [139], but also fundamental to normal and abnormal developmental processes [140– 142], as are many other miRNAs [143].”
- Child health, developmental plasticity, and epigenetic programming. (2011, background): “Some of the first miRNAs that were discovered, such as the let-7 family of miRNAs, are master regulators of developmental differentiation, both in early embryos and adult tissues (103, 104).”
- Improved classification of breast cancer by analysis of genetic alterations and gene expression profiling (2011, background): “up-regulation of mir-21 (reviewed in (11)), mir-17-92 cluster (reviewed in (12)), mir-26a (13), and down-regulation of let-7 family members (reviewed in (14)).”
- Mesenchymal stem cell secretes microparticles enriched in pre-microRNAs (2009, background): “A most notable observation was that 9 of the 13 members in one of the most highly conserved and developmentally important human let-7 family (24,25) were expressed in MSCs.”
- TUT4 in concert with Lin28 suppresses microRNA biogenesis through pre-microRNA uridylation. (2009, background): “let-7 has been implicated in cell differentiation in mammals (Bussing et al., 2008) and nematodes (Roush and Slack, 2008).”
- MicroRNAs in human cancer. (2013, positive): “let-7/98 cluster Ubiquitous Multiple members (chromosomes 3, 9, 11, 19, 21, 22, X) TS CLL [ 136 ] , lymphoma [ 137 ] , gastric [ 138 ] , lung [ 139 ] , prostate [ 9 ] , breast [ 140 ] , ovarian [ 138 ] , colon [ 138 ] , leiomyoma [ 138 ] , melanoma [ 138 ]”
- The Imprinted H19 LncRNA Antagonizes Let-7 MicroRNAs (2013, background): “Since high let-7 levels are generally associated with increased differentiated states (Roush and Slack, 2008), we hypothesized that H19 might serve to inhibit let-7 activity, thereby preventing precocious differentiation.”